|
ZNF445 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.645600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.971900E-04 |
| Normal-vs-Stage2 |
1.307420E-01 |
| Normal-vs-Stage3 |
8.564400E-03 |
| Normal-vs-Stage4 |
5.373300E-04 |
| Stage1-vs-Stage2 |
6.475800E-01 |
| Stage1-vs-Stage3 |
9.573000E-01 |
| Stage1-vs-Stage4 |
2.587400E-01 |
| Stage2-vs-Stage3 |
7.017000E-01 |
| Stage2-vs-Stage4 |
2.875200E-01 |
| Stage3-vs-Stage4 |
3.246400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.793400E-04 |
| Normal-vs-AfricanAmerican |
2.339200E-03 |
| Normal-vs-Asian |
4.772200E-02 |
| Caucasian-vs-AfricanAmerican |
7.847400E-01 |
| Caucasian-vs-Asian |
8.367600E-01 |
| AfricanAmerican-vs-Asian |
9.140400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.215430E-04 |
| Normal-vs-Female |
4.681400E-01 |
| Male-vs-Female |
4.835900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.135200E-03 |
| Normal-vs-Extreme_Weight |
1.93976999999235E-05 |
| Normal-vs-Obese |
2.495900E-02 |
| Normal-vs-Extreme_Obese |
8.316700E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.755970E-01 |
| Normal_Weight-vs-Obese |
3.794800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.891200E-01 |
| Extreme_Weight-vs-Obese |
1.375630E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.135600E-01 |
| Obese-vs-Extreme_Obese |
3.797400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.749210E-01 |
| Normal-vs-Age(41-60Yrs) |
9.376100E-03 |
| Normal-vs-Age(61-80Yrs) |
9.72660000000403E-05 |
| Normal-vs-Age(81-100Yrs) |
9.236100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.416000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.946170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.312100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.242300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.665560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.035400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.156300E-03 |
| Normal-VS-Type2 PRCC |
6.56790000053142E-07 |
| Normal-VS-KIRP CIMP |
5.181200E-01 |
| Normal-VS-Unclassified PRCC |
3.242400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.022270E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.873600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.539000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.112490E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.163710E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.741400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.04659999999868E-07 |
| Normal-vs-N1 |
7.694200E-02 |
| Normal-vs-N2 |
1.971720E-02 |
| N0-vs-N1 |
4.535700E-02 |
| N0-vs-N2 |
9.140000E-01 |
| N1-vs-N2 |
3.400800E-01 |
|
|
